Now Reading
$12.5 million latest gift from Ken Griffin brings Memorial Sloan Kettering’s expertise to South Florida- as his philanthropic giving tops over $5.7 billion
Dark Light

$12.5 million latest gift from Ken Griffin brings Memorial Sloan Kettering’s expertise to South Florida- as his philanthropic giving tops over $5.7 billion

For a family facing a cancer diagnosis, distance is its own burden. It shows up as flights to New York, weeks in hotel rooms, time away from work and children, and the strain of trying to get world-class care while staying close to the people who matter most.

Ken Griffin’s newest gift aims to ease that burden. With $12.5 million, Citadel and Griffin Catalyst founder and founder of Griffin is helping bring Memorial Sloan Kettering Cancer Center’s expertise to patients in Miami, where they can be treated close to home.

The gift supports a deeper partnership between Baptist Health South Florida’s Herbert Wertheim Cancer Institute and MSK, one of the most respected names in cancer medicine.

The Wertheim Cancer Institute is now a Memorial Sloan Kettering Care Partner.

The designation came after MSK carried out a thorough review of the Institute’s clinical infrastructure, care processes, and outcomes, and confirmed that it meets MSK’s Standards of Care.

No other cancer program in Florida holds this status.

What it means for patients is concrete. Doctors from Wertheim and MSK will design and run clinical trials together in medical oncology, radiation oncology, and surgery, so South Floridians can join new studies without moving across the country.

 Patients who want a second opinion will have a simpler referral process.

Pathology second opinions, where a few days can change a treatment plan, get a faster track.

Physicians will also have more chances to train and learn from each other.

Through all of this, patients keep seeing their own local oncologists.

The two institutions aren’t starting from scratch, either.

The Wertheim Cancer Institute has been part of the MSK Cancer Alliance for nine years, and this step turns a long relationship into a closer working partnership.

Griffin gave the credit to the man whose name is on the building. “Herbert Wertheim’s extraordinary generosity is helping transform cancer care in South Florida,” he said.

“I am honored to build on his commitment by supporting the collaboration between Baptist Health and Memorial Sloan Kettering Cancer Center.

Together, these extraordinary teams will help more patients overcome cancer and give families more time with the people they love.”

It’s a gracious way to give.

He presents the gift as adding to another donor’s legacy instead of competing with it, and he describes success simply: more time with family.

The people leading both institutions were just as warm.

Bo Boulenger, president and CEO of Baptist Health, called the designation a milestone that reflects a shared commitment to transforming cancer care across the region, one that lets patients “remain close to home to receive cutting-edge cancer care.”

Selwyn M. Vickers, M.D., president and CEO of Memorial Sloan Kettering, put the idea behind the partnership in one sentence: “Everyone should have access to exceptional cancer care close to home.”

He said the partnership extends 140 years of MSK expertise to the region.

Leonard Kalman, M.D., interim executive medical director of the Wertheim Cancer Institute, called it “a deeper and more functional alliance” that will continue to raise the level of care for patients and families.

The gift also connects two places that already mean a great deal to Griffin. He is a longtime supporter of both institutions.

At MSK, he and the David Geffen Foundation gave a historic $400 million to advance patient care and research, part of which is funding a new cancer pavilion under construction in Manhattan.

At Baptist Health, he recently gave $75 million to advance neuroscience care, and the hospital system renamed its program the Baptist Health Kenneth C. Griffin Neuroscience Institute.

This new gift joins those two commitments so that MSK’s reach now extends into a South Florida system Griffin has already helped strengthen.

The gift fits how Griffin has approached philanthropy for years.

He looks for evidence-based ideas that can grow and produce measurable results, much like his approach at Citadel.

“I want to be seen first and foremost as a person who supports problem solvers,” he has said.

In medicine, that has meant backing the clinicians and researchers who turn discoveries into treatment, including a $50 million gift to the University of Miami Health System to speed up new therapies and widen access to clinical trials.

In education, it has meant opening doors early and keeping them open: a gift to Harvard estimated at $500 million, $20 million to Miami Dade College for scholarships, and major support for Success Academy, including $50 million to launch the network in Miami.

His most ambitious gift came just weeks ago.

Griffin committed $3 billion to Carnegie Mellon University, which the university calls the largest gift ever made by an individual to higher education.

The $2 billion will fund a new Carnegie Mellon campus in Miami’s Wynwood neighborhood.

The other $1 billion goes to Pittsburgh, where the top-ranked computer science school now bears his name.

“This may be the most impactful investment I will make in my lifetime—both for Miami and for our nation,” he said at the time.

Taken together, the numbers are remarkable.

Griffin has now given more than $5.7 billion to charitable causes over his lifetime, including about $2.4 billion in South Florida alone since he moved Citadel’s headquarters to Miami.

Those totals come from his own spokesperson.

The billion-dollar gifts draw the headlines, but this $12.5 million may be among the most personal he has made.

It will be measured in trials a patient can join without leaving home, second opinions that arrive in days instead of weeks, and families who get to stay together through one of the hardest experiences of their lives.


© 2026 Lifestyles Magazine International. All Rights Reserved.